Advertisement

Effects of centrally acting drugs on the activity of tyrosine hydroxylase in the rat midbrain

  • B. Bhagat
Chapter

Abstract

The word ‘catecholamines’ applies to any compound which has a catechol nucleus (a benzene ring with two adjacent hydroxyl groups) and an amine-containing side chain. There are three naturally occurring catecholamines: dopamine (DA), noradrenaline (NA) and adrenaline. Dopamine has two functions: it acts as a precursor to NA and also functions as a neurotransmitter in certain areas of the brain. Histochemical and biochemical studies have revealed the presence of separate neuronal cells in the central nervous system (CNS) in which DA is predominant rather than NA. Dopamine is particularly abundant in the striatum. Noradrenaline is a neurotransmitter and is present primarily in the sympathetic neurones of the peripheral nervous system (PNS) and of the CNS. When released, it acts locally on the effector cells of certain smooth muscle, adipose tissue, heart and brain. Adrenaline is found mostly in the chromaffin cells of the adrenal medulla. It is also found in small amounts in certain areas of the brain. It is released as a hormone and acts on many distant effector cells via the blood stream.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alousi, A. and Weiner, N. (1966). ‘The regulation of norepinephrine synthesis in sympathetic nerves: Effect of nerve stimulation, cocaine and catecholamine-releasing agents’, Proc. natn., Acad. Sci. U.S.A., 56, 1491–1496CrossRefGoogle Scholar
  2. Bhagat, B. (1971). Recent Advances in Adrenergic Mechanisms, Charles C. Thomas, Springfield, IllinoisGoogle Scholar
  3. Bhagat, B. and Friedman, E. (1969). ‘Factors involved in maintenance of cardiac catecholamine contents: Relative importance of synthesis and re-uptake’, Br. J. Pharmac., 37, 24–33CrossRefGoogle Scholar
  4. Carlsson, A. (1959). ‘The occurrence, distribution and physiological role of catecholamines in the nervous system’, Pharmac. Rev., 11, 490–493Google Scholar
  5. Dahlström, A. and Häggendal, J. (1966). ‘Some quantitative studies on the noradrenaline content in the cell bodies and terminal of a sympathetic adrenergic neuron system’, Acta physiol. scand., 67, 271–277PubMedCrossRefGoogle Scholar
  6. Levitt, M., Spector, S. Sjoerdsma, A. and Udenfriend, S. (1965). ‘Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart’, J. Pharmac. exp. Ther., 148, 1–8Google Scholar
  7. Mueller, R. A., Thoenen, H. and Axelrod, J. (1969a). ‘Compensatory increase in adrenal tyrosine hydroxylase activity after chemical sympathectomy’, Science, 163, 468–469PubMedCrossRefGoogle Scholar
  8. Muller, R. A., Thoenen, H. and Axelrod, J. (1969b). ‘Increase in tyrosine hydroxylase activity after reserpine administration’, J. Pharmac. exp. Ther., 169, 74–79Google Scholar

Copyright information

© The Contributors 1976

Authors and Affiliations

  • B. Bhagat
    • 1
  1. 1.Department of PhysiologySt Louis University School of MedicineSt LouisUSA

Personalised recommendations